GILD
Gilead Sciences Inc.
$135.46
+$1.10(+0.82%)
60
Overall
80
Value
40
Tech
60
Quality
Market Cap
$152.38B
Volume
2.52M
52W Range
$104.46 - $157.29
Target Price
$159.20
Order:
Income Statement
| Metric | Trend | Chart | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec | 2025 Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||||||
| Total Revenue | $30.4B | $26.1B | $22.1B | $22.4B | $24.7B | $27.3B | $27.3B | $27.1B | $28.8B | $29.4B | ||
| Total Revenue | $30.4B | $26.1B | $22.1B | $22.4B | $24.7B | $27.3B | $27.3B | $27.1B | $28.8B | $29.4B | ||
| COST OF GOODS SOLD | ||||||||||||
| Cost of Revenue | $4.3B | $4.4B | $4.9B | $4.7B | $4.6B | $6.6B | $5.7B | $6.5B | $6.3B | $6.2B | ||
| GROSS PROFIT | ||||||||||||
| Gross Profit | $26.1B | $21.7B | $17.3B | $17.8B | $20.1B | $20.7B | $21.6B | $20.6B | $22.5B | $23.2B | ||
| OPERATING EXPENSES | ||||||||||||
| Operating Expenses | $8.5B | $7.6B | $-8.0B | $8.4B | $10.2B | $10.8B | $11.6B | $13.0B | $16.7B | $12.6B | ||
| Research & Development | $5.1B | $3.7B | $-3.9B | $4.1B | $5.0B | $5.5B | $5.9B | $6.9B | $10.6B | $6.8B | ||
| Research Expense | -- | -- | -- | -- | -- | $5.5B | $5.0B | $5.7B | $5.9B | $5.8B | ||
| Selling, General & Administrative | $3.4B | $3.9B | $4.1B | $4.4B | $5.2B | $5.2B | $5.7B | $6.1B | $6.1B | $5.8B | ||
| Selling & Marketing Expenses | -- | -- | -- | -- | -- | $735.0M | $778.0M | $826.0M | $869.0M | -- | ||
| General & Administrative Expenses | -- | -- | -- | -- | -- | $5.2B | $5.7B | $6.1B | $6.1B | $5.8B | ||
| Promotion & Advertising | -- | -- | -- | -- | -- | $735.0M | -- | -- | -- | -- | ||
| Salaries & Wages | -- | -- | -- | -- | -- | $-100.0M | -- | -- | -- | -- | ||
| Amortization | -- | -- | -- | -- | -- | $33.5B | $28.9B | $26.5B | $19.9B | -- | ||
| Other Operating Expenses | -- | -- | -- | -- | -- | $-147.0M | -- | -- | -- | -- | ||
| OPERATING INCOME | ||||||||||||
| Operating income | $17.6B | $14.1B | $9.3B | $9.3B | $9.9B | $9.9B | $7.3B | $7.6B | $1.7B | $10.0B | ||
| EBITDA | $19.2B | $15.9B | $10.3B | $7.6B | $4.1B | $11.3B | $8.9B | $10.5B | $4.4B | $13.6B | ||
| NON-OPERATING ITEMS | ||||||||||||
| Interest Expense (Non-Operating) | $964.0M | $1.1B | $1.1B | $995.0M | $984.0M | $1.0B | $935.0M | $944.0M | $977.0M | $1.0B | ||
| Net Non-Operating Interest Income/Expense | $-964.0M | $-1.1B | $-1.1B | $-995.0M | $-984.0M | $-1.0B | $-935.0M | $-944.0M | $-977.0M | $-1.0B | ||
| Gain on Sale of Securities | -- | -- | -- | -- | -- | $21.0M | -- | $376.0M | $281.0M | $451.0M | ||
| Other Income/Expense | $-428.0M | $-523.0M | $422.0M | $3.2B | $7.3B | $639.0M | $-4.2B | $-148.0M | $4.2B | $-208.0M | ||
| Other Special Charges | $428.0M | $523.0M | $676.0M | $1.9B | $-1.4B | $-639.0M | $-581.0M | $198.0M | $6.0M | $798.0M | ||
| SPECIAL ITEMS | ||||||||||||
| Restructring And Mn A Income | $-12.9B | $-4.5B | -- | -- | -- | -- | -- | -- | -- | -- | ||
| Special Income Charges | -- | -- | $-1.1B | $-5.1B | $-5.9B | -- | -- | $-527.0M | $-188.0M | -- | ||
| Other Impairment Of Capital Assets | -- | -- | -- | -- | -- | -- | $2.7B | $50.0M | $4.2B | $590.0M | ||
| PRE-TAX INCOME | ||||||||||||
| EBIT | $18.1B | $14.6B | $8.9B | $6.2B | $2.7B | $9.3B | $6.7B | $7.8B | $1.7B | $10.8B | ||
| Pre-Tax Income | $17.1B | $13.5B | $7.8B | $5.2B | $1.7B | $8.3B | $5.8B | $6.9B | $690.0M | $9.8B | ||
| INCOME TAX | ||||||||||||
| Tax Provision | $3.6B | $8.9B | $2.3B | $-204.0M | $1.6B | $2.1B | $1.2B | $1.2B | $211.0M | $1.3B | ||
| NET INCOME | ||||||||||||
| Net Income | $13.5B | $4.6B | $5.5B | $5.4B | $123.0M | $6.2B | $4.6B | $5.7B | $480.0M | $8.5B | ||
| Net Income (Continuing Operations) | $13.5B | $4.6B | $5.5B | $5.4B | $123.0M | $6.2B | $4.6B | $5.6B | $480.0M | $8.5B | ||
| Net Income (Discontinued Operations) | $13.5B | $4.6B | $5.5B | $5.4B | $123.0M | $6.2B | $4.6B | $5.7B | $480.0M | $8.5B | ||
| Net Income (Common Stockholders) | $13.5B | $4.6B | $5.5B | $5.4B | $123.0M | $6.2B | $4.6B | $5.7B | $480.0M | $8.5B | ||
| Normalized Income | $-32.2B | $8.8B | $5.1B | $-95.0M | $-4.5B | -- | -- | -- | -- | $10.3B | ||
| TOTALS | ||||||||||||
| Total Expenses | $12.8B | $12.0B | $13.9B | $13.1B | $14.8B | $17.4B | $17.3B | $19.5B | $22.9B | $18.8B | ||
| SHARE & EPS DATA | ||||||||||||
| Average Shares Outstanding | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | ||
| Average Shares Outstanding (Diluted) | $1.4B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | ||
| Shares Outstanding | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.3B | $1.2B | $1.2B | $1.2B | $1.2B | ||
| Basic EPS | $10.08 | $3.54 | $4.2 | $4.24 | $0.10 | $4.96 | $3.66 | $4.54 | $0.38 | $6.84 | ||
| Basic EPS (Continuing Operations) | $10.08 | $3.54 | $4.2 | $4.24 | $0.10 | $4.96 | $3.66 | $4.54 | $0.38 | $6.84 | ||
| Diluted EPS | $9.94 | $3.51 | $4.17 | $4.22 | $0.10 | $4.93 | $3.64 | $4.5 | $0.38 | $6.78 | ||
| Diluted EPS (Continuing Operations) | $9.94 | $3.51 | $4.17 | $4.22 | $0.10 | $4.93 | $3.64 | $4.5 | $0.38 | $6.78 | ||
| Dividend Per Share | $1.88 | $2.08 | $2.28 | $2.52 | $2.72 | $2.84 | $2.92 | $3 | $3.08 | $3.16 | ||
| OTHER METRICS | ||||||||||||
| Development Expense | -- | -- | -- | -- | -- | -- | $944.0M | $1.2B | $4.7B | $1.0B | ||
| Earnings from equity interest | -- | -- | -- | -- | -- | $-3.6B | -- | -- | -- | -- | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | -- | -- | -- | $-3.6B | -- | -- | -- | -- | ||
| Minority Interests | $13.0M | $-16.0M | $-5.0M | $22.0M | $34.0M | $24.0M | $26.0M | $52.0M | -- | -- | ||
| Other Gand A | -- | -- | -- | -- | -- | $5.2B | $5.7B | $6.1B | $6.1B | $5.8B | ||
| Othspecchg | -- | -- | $-1.1B | $-5.1B | $-5.9B | -- | -- | -- | -- | -- | ||
| Restruct | $-12.9B | $-4.5B | -- | -- | -- | -- | -- | -- | -- | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GILD | $135.46 | +0.8% | 2.52M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |